YOUR CLINICAL BENEFITS, SAVINGS AND PROFIT
Clinical Benefits
Percentage Mastitis
Reduction
with Teatseal
(See References)
10.2
Mastitis cases
eliminated
with Teatseal
Financial Benefits $/Season
| Saved money from lost production | $1,370.88 | $1,370.88 |
| Saved value on Heifers not culled | $1,800.00 | $1,800.00 |
| Savings on Mastitis Treatments | $1,101.60 | $1,101.60 |
| Total savings | $4,272.48 | $4,272.48 |
| Cost of Teatseal Treatment | $1,720.00 | $1,720.00 |
Profit $/Season
$2528.48
$2528.48
YOUR CLINICAL BENEFITS, SAVINGS AND PROFIT
Clinical Benefits
Percentage Mastitis
Reduction
with Teatseal
(See References)
10.2
Mastitis cases
eliminated
with Teatseal
Financial Benefits $/Season
| Saved money from lost production | $1,370.88 | $1,370.88 |
| Saved value on Cows not culled | $1,800.00 | $1,800.00 |
| Savings on Mastitis Treatments | $1,101.60 | $1,101.60 |
| Total savings | $4,272.48 | $4,272.48 |
| Cost of Teatseal Treatment | $1,720.00 | $1,720.00 |
Profit $/Season
$2528.48
$2528.48
Factors Not Included
- Clinical mastitis increases risk of empty cows.
- Cost of higher SCC.
- Cost of labor to treat cows etc.
- Risk of grading.
- Re-treatments.
- Loss of production from increased SCC next lactation.
- Stress.
References
Quarter-level analysis of subclinical and clinical mastitis in primiparous heifers following the use of a teat sealant of an injectable antibiotic, or both, precalving
Parker, et al. 2008
Subclinical and clinical mastitis in heifers following the use of a teat sealant precalving
Parker, et al. 2008
Loss in milk yield and related composition changes resulting from clinical mastitis in dairy cows
Hortet and Seegers. 1998
Economics of clinical mastitis and its control options in heifers in pasture-grazing systems
Compton and McDougall. 2010
Interrelationships of somatic cell count, mastitis, and milk yield in a low somatic cell count herd
Deluyker et al. 1993
Effect of an intramammary teat seal and dry cow antibiotic in relation to dry period length on postpartum mastitis
Berry and Hillerton. 2007
Effectiveness of an internal teat seal in the prevention of new intramammary infections during the dry and early-lactation periods in dairy cows when used with a dry cow intramammary antibiotic
Godden et al. 2003
Efficacy of blanket treatment of cows and heifers with an internal teat sealant in reducing the risk of mastitis in dairy cattle calving on pasture
Laven and Lawrence. 2008
Comparison of the efficacy of cloxacillin along and cloxacillin combined with an internal teat sealant for dry-cow therapy
Newton et al. 2008
The use of an internal teat sealant in combination with cloxacillin dry cow therapy for the prevention of clinical and subclinical mastitis in seasonal calving dairy cows
Runciman et al. 2010
Mandatory Statements
By downloading the Teatseal calculator (Calculator), and each time you access and/or use the Calculator, you agree to be bound by these terms and conditions. In these terms and conditions, we means Zoetis New Zealand Limited.
The Calculator is for use by New Zealand residents only. The Calculator is based on the New Zealand registered label claims of the products featured, correct as at 16 February 2015. From time to time we may update the Calculator. Accordingly, you should regularly check for software updates to ensure the Calculator contains up to date information. You should always check the applicable product label to ensure correct withholding periods are observed.
To the fullest extent permissible by law:
- (a) We disclaim all representations or warranties of any kind, express or implied, regarding the calculator; and
- (b) We exclude all liability or responsibility to anyone for any losses, expenses, costs or damages arising from claims made, whether in contract, tort (including negligence) or otherwise, relating to any action or failure to act in reliance on the Calculator.
The Calculator is our intellectual property. We license you to use the Calculator. We must not otherwise, copy, modify, distribute, re-sell or dispose of the Calculator in any way without obtaining our written permission.
The calculations and values in this application are accurate as at 16 February 2015. Check for updates to ensure the most current information. While every effort has been made to ensure accuracy, the calculator provides an estimate only. Zoetis Inc. does not warrant that the application or data will be uninterrupted or error-free or that defects will be corrected. Your download and use of the application and data is at your sole risk and you will be solely responsible for any damage or loss that results from such use.
Zoetis New Zealand Limited. Level 5, 8 Mahuhu Crescent, Auckland 1010, New Zealand. Tel 0800 963 847, Fax 0800 628 629.
ORBENIN and CLAVULOX are registered trademarks of GlaxoSmithKline NZ Ltd. ACVM Nos. A3664 and A5945.
MASTALONE, LINCOCIN and TEATSEAL are registered trademarks of Zoetis Inc. or its subsidiaries. ACVM Nos. A0829, A7712 and A7294.
All products are Restricted Veterinary Medicines; Available only under Veterinary Authorisation.
